Statizoid

SEAR: statistics and indicators

75 indicators and 1,863 data points for SEAR, collected automatically from official statistical sources.

Indicators
75
Data points
1,863

Browse SEAR data by subject

Key indicators for SEAR

IndicatorLatest YearRank Trend
Total tetanus - number of reported cases 164 2025 14th volatile
Pertussis - number of reported cases 2,449 2025 16th volatile
Infant mortality rate (probability of dying between birth and age 1) 23.13 2024 8th falling
Under-five mortality rate 26.66 2024 8th falling
Maternal mortality ratio 96.26 2023 6th volatile
Number of deaths among children ages 5 to 9 years 57,932 2024 8th volatile
Mortality rate among children ages 5 to 9 years 1.94 2024 8th volatile
Number of deaths among adolescents 67,025 2024 6th falling
Proportion of population with primary reliance on polluting fuels and 39.3% 2023 6th falling
Population with primary reliance on polluting fuels and technologies 493.79 2023 4th falling
Population with primary reliance on clean fuels and technologies for 763.07 2023 2nd volatile
Women who have their need for family planning satisfied with modern 76.8% 2025 5th rising
Proportion of population with primary reliance on fuels and 37.5% 2023 6th falling
Population with primary reliance on fuels and technologies for 470.67 2023 4th falling
Prevalence of diabetes, age-standardized 21.12 2022 3rd rising
Prevalence of diabetes, crude 20.36 2022 3rd rising
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 96.0% 2025 1st rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage 96.0% 2025 1st rising
New HIV infections 0.1 2025 5th volatile
BCG immunization coverage among 1-year-olds (%) 91.0% 2025 7th rising
Mean total cholesterol, crude 4.3 2018 10th flat
Mean total cholesterol, age-standardized 4.3 2018 10th flat
Mean HDL cholesterol, crude 1.1 2018 10th flat
Stunting prevalence among children under 5 years of age (%) 29.7% 2024 5th falling
Stunting numbers among children under 5 years of age (millions) 44,289 2024 7th falling
Overweight numbers among children under 5 years of age (thousands) 4,932 2024 14th falling
Overweight prevalence among children under 5 years of age (%) 3.4% 2024 18th flat
Adolescent mortality rate 2.27 2021 6th falling
Incidence of tuberculosis 201 2024 4th falling
Deaths due to tuberculosis among HIV-negative people 24 2024 4th falling
Number of women of reproductive age (aged 15-49 years) with anaemia 229,036 2023 5th rising
Domestic private health expenditure (PVT-D) as percentage of current 46.8% 2023 2nd falling
Estimated number of people (all ages) living with HIV 3.60 million 2025 6th falling
Prevalence of HIV among adults aged 15 to 49 0.2% 2025 8th falling
Estimated antiretroviral therapy coverage among people living with HIV 22.0% 2025 12th volatile
Hypertension: effective treatment coverage (controlled hypertension) 13.3% 2019 13th volatile
Hypertension treatment coverage among adults aged 30-79 with 31.0% 2019 13th rising
Hypertension among adults aged 30-79 years, prevalence 31.17 2019 10th rising
Hypertension: diagnosis coverage among adults aged 30-79 with 39.8% 2019 16th rising
Hypertension: diagnosis coverage among adults aged 30-79 with 39.0% 2019 15th rising
Hypertension among adults aged 30-79 years, prevalence, crude 30.3 2019 16th rising
Number of new HIV infections 82,000 2025 10th falling
Births attended by skilled health personnel 90.9% 2025 7th rising
Number of current of tobacco users, estimate 295.94 million 2030 4th falling
Estimate of current tobacco use prevalence (%) 19.4% 2030 5th falling
Number of current tobacco smokers, estimate 135.49 million 2030 6th falling
Inactivated first-dose polio vaccine (IPV1) immunization coverage 94.0% 2025 2nd rising
Low birth weight number 7,446 2020 5th falling
Concentrations of fine particulate matter 43.74 2023 1st falling
Prevalence of anaemia in non-pregnant women (aged 15-49) 23.5% 2019 1st rising
Number of children aged 6-59 months with anaemia 83,222 2019 5th falling
Prevalence of anaemia in children aged 6-59 months 49.0% 2019 5th falling
Prevalence of anaemia in pregnant women (aged 15-49) 25.1% 2019 1st rising
Mean hemoglobin level of children aged 6-59 months 109 2019 10th rising
Estimated number of MDR/RR-TB incident cases 150,000 2024 2nd flat
Mean hemoglobin level of women of reproductive age 119 2019 12th flat
Number of deaths attributed to non-communicable diseases, by type of 1.50 million 2019 9th rising
Hepatitis B surface antigen (HBsAg) prevalence 0.2% 2024 8th falling
Mean hemoglobin level of non-pregnant women 120 2019 12th flat
Estimated number of malaria cases 2.74 million 2024 6th volatile
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 4th flat
Estimated number of children needing antiretroviral therapy based on 60,000 2025 4th falling
Estimated antiretroviral therapy coverage among children 11 2025 12th volatile
HPV immunization coverage estimates among primary target cohort (9-14) 8.0% 2025 11th volatile
Smear-positive tuberculosis treatment-success rate 89.0% 2011 3rd rising
Number of indigenous P. falciparum malaria cases 272,829 2021 6th volatile
Number of suspected malaria cases 121.64 million 2021 4th falling
Number of malaria positive cases by microscopy 292,126 2021 8th volatile
Number of malaria suspects examined by microscopy 91.09 million 2021 2nd falling
Percentage of people living with HIV who have suppressed viral loads 74 2025 3rd rising
Percentage of people living with HIV receiving treatment who have 98 2025 1st flat
Number of malaria positive cases by rapid diagnostic test 266,650 2021 8th flat
Number of malaria suspects examined by rapid diagnostic test 30.51 million 2021 4th rising
Number of imported malaria cases 1,231 2021 8th volatile
Women of reproductive age (aged 15-49 years) who have their need for 77.3% 2024 7th rising

Share, cite or embed this page

Cite this page

SEAR: statistics and indicators. Statizoid, drawing on Statizoid. Retrieved 26 September 2026, from https://statizoid.com/place/sear/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under the original publishers' licences; please keep the attribution.

<a href="https://statizoid.com/place/sear/">SEAR: statistics and indicators</a> — Statizoid